GNH USA

Europe — EMA

Lamivudine/Zidovudine Aurobindo

GNH USA supplies Lamivudine/Zidovudine Aurobindo (Lamivudine/Zidovudine), a nucleoside reverse transcriptase inhibitor for HIV-1 infection.

Zidovudine, Lamivudine

Request sourcing

1
Pack/s

What is Zidovudine, Lamivudine?

Lamivudine and Zidovudine, the active ingredient in Lamivudine/Zidovudine Aurobindo, is a nucleoside reverse transcriptase inhibitor presented as an oral tablet for oral use. It is indicated for the treatment of HIV-1 infection in adults and children as part of combination antiretroviral therapy.

GNH USA supplies Lamivudine/Zidovudine Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Zidovudine, Lamivudine used for?

Lamivudine/Zidovudine is a nucleoside reverse transcriptase inhibitor used in the management of HIV infection.

- HIV‑1 infection (adults): reduces plasma HIV RNA levels when combined with other antiretrovirals. - HIV‑1 infection (children): helps achieve viral suppression in pediatric patients. - HIV‑1 infection (treatment‑naïve patients): forms part of first‑line combination regimens.

What are the side effects of Zidovudine, Lamivudine?

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Headache: transient cranial discomfort. - Fatigue: general tiredness. - Anemia: reduced red blood cell count. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Lactic acidosis: severe metabolic disturbance. - Hepatomegaly with steatosis: liver enlargement with fat accumulation. - Bone marrow suppression: significant drops in blood cell lines. - Hypersensitivity reactions: rash, fever, or organ involvement. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction.

What precautions apply to Zidovudine, Lamivudine?

Patients should be monitored for specific safety considerations before and during therapy.

- Renal function: adjust dosing in severe renal impairment. - Hepatic function: monitor liver enzymes regularly. - Hematologic status: check complete blood count for anemia or neutropenia. - Pregnancy: use only if potential benefits outweigh risks. - Drug resistance: avoid using as monotherapy to prevent resistance development. - Store at ambient temperature: keep in original container, protect from moisture and light.

What does Zidovudine, Lamivudine interact with?

Lamivudine/Zidovudine may interact with several other medicines, requiring careful management.

Major Interactions (Avoid): - Didanosine: increased risk of mitochondrial toxicity. - Stavudine: additive bone‑marrow suppression. - Alcohol: heightened hepatotoxicity.

Moderate Interactions (Monitor Closely): - Nephrotoxic agents: monitor renal function when co‑administered. - Anticoagulants: may alter INR values, requiring dose adjustments.

Frequently asked questions

What is Lamivudine/Zidovudine used for?+
Lamivudine/Zidovudine is used as part of combination antiretroviral therapy to treat HIV‑1 infection in adults and children. It helps lower the amount of virus in the blood and supports immune system recovery when taken with other approved HIV medicines.
How does Lamivudine/Zidovudine work?+
Both lamivudine and zidovudine are nucleoside analogues that are converted inside cells to active triphosphate forms. These active metabolites inhibit HIV reverse transcriptase, causing premature termination of viral DNA synthesis and preventing the virus from replicating.
What is the usual dose of Lamivudine/Zidovudine?+
The specific dose and dosing schedule of Lamivudine/Zidovudine are determined by the prescribing healthcare professional based on the patient’s age, weight, renal function, and overall treatment plan. Patients should follow the prescriber’s instructions exactly.
Is Lamivudine/Zidovudine safe during pregnancy or breastfeeding?+
Safety in pregnancy and lactation has not been fully established. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.
How do I order Lamivudine/Zidovudine from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Lamivudine/Zidovudine compare with other antiretroviral options?+
Lamivudine/Zidovudine is a fixed‑dose combination of two NRTIs, offering the convenience of a single tablet compared with separate agents. It is generally used in first‑line regimens, whereas newer agents such as integrase inhibitors may provide different efficacy or side‑effect profiles. Choice of therapy depends on resistance patterns, patient tolerance and clinical guidelines.
What are the storage and handling requirements for Lamivudine/Zidovudine?+
Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original packaging, protect from moisture and direct light, and ensure the container is tightly closed to maintain product stability.
How is Lamivudine/Zidovudine administered?+
Lamivudine/Zidovudine is taken orally, usually once daily, with or without food as directed by the prescriber. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.
What are the most serious risks associated with Lamivudine/Zidovudine?+
Serious risks include lactic acidosis, severe hepatomegaly with steatosis, bone‑marrow suppression leading to anemia or neutropenia, and hypersensitivity reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience unexplained fatigue, abdominal pain, rapid weight loss, or severe skin reactions.
Who should not use Lamivudine/Zidovudine?+
Patients with known hypersensitivity to lamivudine, zidovudine, or any excipients in the formulation should avoid this medication. It is also contraindicated in individuals with severe bone‑marrow failure or those who cannot be monitored regularly for hematologic toxicity.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Zidovudine, Lamivudine
Route
Oral Use
Manufacturer
Aurobindo Pharma B.V.
Origin
EU

Related products